Cero Therapeutics Hldgs Inc.

13F holders, Q4 2024 (December 31)
1holders
$0.06avg. 13F price*

At the end of Q4 2024, 1 institutions reported holding Cero Therapeutics Hldgs Inc. in their 13F filings. The largest holder was SBI Securities Co., Ltd. ($331).

Company
Cero Therapeutics Hldgs Inc.
CUSIP
71902K303
Latest filing quarter
Q1 2025

History

Number of 13F holders

051015 Q4 2024: 1Q4 2024Q1 2025: 15Q1 2025

Total Exit/New Position Q4 2024

No earlier quarter to compare with.

Ownership 1 holders

SBI Securities Co., Ltd. 0.00% — 5,523 $331

"% of holder's portfolio" is CERO THERAPEUTICS HLDGS INC's weight in each manager's 13F, not the share of Cero Therapeutics Hldgs Inc. the manager owns.